SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-111564
Filing Date
2024-04-25
Accepted
2024-04-25 07:33:09
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d833042d10ka.htm   iXBRL 10-K/A 364578
2 EX-31.3 d833042dex313.htm EX-31.3 3585
3 EX-31.4 d833042dex314.htm EX-31.4 3339
  Complete submission text file 0001193125-24-111564.txt   640116

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cadl-20231231.xsd EX-101.SCH 4599
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cadl-20231231_cal.xml EX-101.CAL 673
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cadl-20231231_def.xml EX-101.DEF 17467
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cadl-20231231_lab.xml EX-101.LAB 23614
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cadl-20231231_pre.xml EX-101.PRE 19079
21 EXTRACTED XBRL INSTANCE DOCUMENT d833042d10ka_htm.xml XML 8985
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40629 | Film No.: 24872984
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)